Navigation Links
Genomic Health Announces Multiple Colon Cancer Studies at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium
Date:1/21/2011

REDWOOD CITY, Calif., Jan. 21, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced presentation of three studies at the American Society of Clinical Oncology® (ASCO®) (1) Gastrointestinal (GI) Cancer Symposium, including one finding that high tumor grade was not a marker of higher recurrence risk in stage II colon cancer, suggesting that other markers, such as the Oncotype DX® Recurrence Score® (RS) test as well as T-stage and mismatch repair (MMR) status, should be considered by physicians during the treatment decision-making process.

"These results presented at ASCO-GI reinforce the value that the Oncotype DX Colon Cancer test provides to physicians, patients and payors," said Steven Shak, M.D., chief medical officer of Genomic Health.  "The Oncotype DX Colon Cancer test, which has been commercially available for the past year, combines the practicality of paraffin-embedded tumor tissue with robust evidence from multiple large independent development and validation studies focused on the specific clinical questions relevant to physicians and patients.  Rigorous comparison of the colon cancer test with conventional markers of recurrence risk, including MMR and T-stage, has demonstrated its independent value.  These data allow physicians and patients to confidently and appropriately incorporate information about individual tumor biology provided by Oncotype DX into treatment decisions in stage II colon cancer.  As with our breast cancer program, we are committed to increasing the clinical utility of our colon cancer franchise through continued research and look forward to expanding the Oncotype DX service by offering MMR testing this year."

Comparative Study Supports Independent Determination of MMR Status by IHC

Previous research suggests that stage II colon cancer patients with deficient mismatch repair (MMR-D) have significantly fewer re
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Everist Genomics Announces External Validation of OncoDefender™-CRC Test for Predicting Recurrence Risk for Stage I and II Colorectal Cancer Patients
2. BioInformatics, LLC New Market Report - Genomics Technologies
3. Transgenomic Reports Third Quarter Financial Results
4. Transgenomic Awarded $1,070,453 From U.S. Government Under the Patient Protection and Affordable Care Act
5. Transgenomic to Hold Third Quarter Financial Results Conference Call on November 15, 2010
6. Transgenomic Develops New Assays to Detect EGFR Mutations Using COLD-PCR
7. Sirius Genomics Announces Issuance of U.S. Patent
8. AutoGenomics Receives FDA Clearance for its INFINITI® CYP2C19 Assay
9. Genomic Health to Announce Third Quarter 2010 Financial Results and Host Conference Call on Monday, November 8, 2010
10. Dr. Eric Johnson Joins Transgenomic as Medical Director for Laboratory Services
11. WaferGen Names Gary P. Schroth, Ph.D., as New SVP, Genomics Research and Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 2014 Research and Markets  has announced ... - Global Industry Analysis, Size, Share, Growth, Trends and ... http://photos.prnewswire.com/prnh/20130307/600769 Transfection ... DNA or RNA) into cells. This technology helps the ... and protein metabolism by affecting the nuclear genes. The ...
(Date:7/11/2014)... July 11, 2014 /CNW/ - Sunovion Pharmaceuticals Canada Inc. ... (eslicarbazepine acetate) for use as a once-daily adjunctive ... with epilepsy who are not satisfactorily controlled with conventional ... in patients under 18 years of age. ... disorders and according to Epilepsy Canada, it affects 0.6% ...
(Date:7/10/2014)... Women in the West African ... additional family planning option. Sayana® Press has the ... levels of the health system and in communities ... used contraceptive—Pfizer’s Depo-Provera® (depot medroxyprogesterone acetate)—with the BD ... first of four African countries expected to begin ...
(Date:7/10/2014)... (PRWEB) July 10, 2014 Understanding the ... channel-expressing cell lines, and the gap that currently exists ... that expand its industry-leading portfolio of validated ion channel ... ion channel-expressing cell lines, as ion channels control many ... control this activity creates the potential to treat a ...
Breaking Biology Technology:International Transfection Technology Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019 2Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 2Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 3Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 4Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 2Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 3Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 4Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 5Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 6Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 2Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 3
... Medical Inc. (OTCBB:ONCS), which is developing its ... treat solid tumor cancers, today announced that Punit ... presenting at the 10th Annual BioPartnering North America ... (Logo:  http://photos.prnewswire.com/prnh/20110314/MM64943LOGO ) 10th ...
... Plants often regarded as common weeds such as thistles, ... fragile food webs on UK farms according to Researchers ... (BBSRC). , Published tomorrow in Science , researchers ... occur between the different food webs commonly found on ...
... crucial to the operation of most of the powerplants that ... natural gas or nuclear fuel. It is also the key ... there are still large gaps in the scientific understanding of ... steam back into water in a powerplant, or to condense ...
Cached Biology Technology:OncoSec to Present at 10th Annual BioPartnering North America 2OncoSec to Present at 10th Annual BioPartnering North America 3Farm 'weeds' have crucial role in sustainable agriculture 2Making droplets drop faster 2Making droplets drop faster 3
(Date:7/10/2014)... Fe, Albuquerque, and other major cities in New Mexico, ... treated municipal wastewater rather than precious potable water supplies. ... 40% of all golf courses receive treated effluent. Reusing ... , Additionally, golf courses and homeowners alike fertilize their ... fertilizer is nitrate. A New Mexico State University turfgrass ...
(Date:7/10/2014)... Florida , July 1, 2014 ... pave way for convenience and improved security: NXT-ID, Inc. (OTCBB: ... (NASDAQ: GOOG ), Apple Inc. (NASDAQ: ... MasterCard Corporation (NYSE: MA) NXT-ID, Inc., (OTCQB: NXTD) a ... pleased to announce that the second series of 30 second ...
(Date:7/10/2014)... , July 3, 2014 ... Market by Type (Swipe And Area), Material (Optical Prism, ... Healthcare, Commercial Security and Banking & Finance), and Geography ... published by MarketsandMarkets, the global Fingerprint Sensors Market is ... a high CAGR of 16.8% from 2014 to 2020. ...
Breaking Biology News(10 mins):'Tailored' water -- the latest in lawn care 2Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 2Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 3Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 4Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 5Fingerprint Sensors Market worth $14.35 Billion by 2020 2Fingerprint Sensors Market worth $14.35 Billion by 2020 3
... causes and effects of hypoxia in Green Bay, part of ... year of an anticipated four-year $1,367,300 project through NOAA,s Coastal ... problem for decades, and recent evidence suggests that it may ... kills to become both more frequent and more extensive with ...
... of Technology have attained very promising results on their initial ... new technique involving mass spectrometry of a single drop of ... in 100 percent of the patients tested. The results can ... & Prevention Research . "Because ovarian cancer is ...
... formidable marine predators, the marine mosasaur Platecarpus , lived in ... to have swum like an eel. That theory is debunked in ... . An international team of scientists have reconceived the animal,s morphology, ... Natural History Museum of Los Angeles County. The ...
Cached Biology News:NOAA awards grant to investigate impacts of land use and climate change on hypoxia in Green Bay 2Initial trials on new ovarian cancer tests exhibit extremely high accuracy 2Mosasaur fossil at Natural History Museum of L.A. County re-explores 85-million-year-old sea monster 2
...
...
... Purity is >95%NEN Radiolabeled Ligands\n\nReceptor-related research has ... of new radiolabeled ligands selected to keep ... wide range of products and services for ... 400 state-of-the-art radioligands. If you do not ...
... (patent pending) was developed using a protein engineering ... DNA binding pocket of wild-type DNase I. These ... for DNA. The result is a versatile enzyme ... and an ability to maintain at least 50% ...
Biology Products: